Table 2.
Log-transformed concentrations of CRP and SAA measured by the two analytical assays (nepholometry and ELISA) in COPD patients and healthy controls
| Entire cohort (n = 133) |
COPD (n = 88) |
Controls (n = 45) |
p value* | |
|---|---|---|---|---|
| logCRP (Ne) | 0.5 (0.4) | 0.6 (0.4) | 0.3 (0.4) | 0.002 |
| logCRP (ELISA) | 0.2 (0.6) | 0.3 (0.5) | 0.04 (0.7) | 0.026 |
| P value† | < 0.001 | < 0.001 | 0.001 | |
| logSAA (Ne) | 0.7 (0.4) | 0.7 (0.4) | 0.5 (0.3) | 0.022 |
| logSAA (ELISA) | 0.7 (0.4) | 0.8 (0.4) | 0.5 (0.5) | 0.003 |
| P value† | NS | NS | NS | |
Data expressed as the mean (standard deviation). *p value calculated by unpaired Student's t test. †p value for the difference between nephelometry and ELISA calculated by paired Student's t test.
logCRP (Ne): log-transformed concentrations of C-reactive protein measured by nephelometry.
logCRP (ELISA): log-transformed concentrations of C-reactive protein measured by ELISA.
logSAA (Ne): log-transformed concentrations of serum amyloid A measured by nephelometry.
logSAA (ELISA): log-transformed concentrations of serum amyloid A measured by ELISA.